Trump Treatment - antibody ****tail5 Oct 2020 10:13
Hi All,
I've been here only 3 months or so but was blown-away by all the innovation and opportunities with HEMO and in my opinion low share price considering all the news coming up. I'm currently on a loss here but it will change and juggling my funds for a top-up at these prices - it's also got to be positive to see the mention of Eli Lilly and antibody from a mouse in below article over the weekend with regards to Advanced humanised mice for disease modelling..........
'What is the antibody ****tail Trump received?
It’s a combination of two antibodies directed against a key protein of the virus that causes COVID-19, SARS-CoV-2. They bind to a region on the main surface spike protein that helps the virus attach to a receptor on human cells called angiotensin-converting enzyme 2 (ACE2). The targeted region is dubbed the receptor binding domain. One antibody comes from a human who had recovered from a SARS-CoV-2 infection; a B cell that makes the antibody was harvested from the person’s blood and the genes for the immune protein isolated and copied. The other antibody is from a mouse, which was engineered to have a human immune system, that had the spike protein injected into it.'
'Could Regeneron’s monoclonal antibody treatment become more widely available through the FDA’s emergency use authorization (EUA) pathway?'
Yes. Both Regeneron and Eli Lilly, which similarly reported encouraging preliminary clinical trial data last month from a single SARS-CoV-2 monoclonal antibody, are discussing the possibility of an EUA with FDA. Lilly reported signs that its antibody reduced the need for hospitalization, but as with Regeneron, too few participants have so far become seriously ill to reach a convincing conclusion to this critical question.'
https://www.sciencemag.org/news/2020/10/heres-what-known-about-president-donald-trump-s-covid-19-treatment